article thumbnail

SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]

Annals of Family Medicine

Sodium-glucose transporter 2 (SGLT-2) inhibitors have been proved to decrease the cardiovascular adverse events in several large randomized controlled trials (RCTS), but evidence limited to patients with type 2 diabetes and ASCVD. Setting or Dataset Five electronic systems of community clinic.

article thumbnail

Patient Violence Travels Cross-Setting: From EMS to ED to Inpatient

Physician's Weekly

Research shows that patient violence spans care settings, starting in the out-of-hospital setting, continuing in the ED, and persisting into inpatient units. Clements, MD, PhD , of Mayo Clinic, and colleagues. in the out-of-hospital setting to 1.06 in non-ED hospital settings. in the ED and 6.37 into a third, and 7.5%

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Maryland's Primary Care Program: incremental progress or breakthrough?

The Health Policy Exchange

Our residency, formerly a collaboration with Providence Hospital, is now known as the Medstar Health/Georgetown-Washington Hospital Center Family Medicine Residency Program. I stepped down as director of the Robert L. Phillips, Jr.

article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

Yes, one year after stopping the medication, patients regain ½ – ⅔ of their previous weight loss: What are other clinical benefits? Cardiovascular Events The SELECT trial 1 randomized 17,604 patients with preexisting CVD and overweight/obesity. Patients with CKD experience less CKD-related events (24% less).

Diabetes 130
article thumbnail

Fecal Microbiota Transplantation Could Be First-Line Therapy for C. Difficile

Physician's Weekly

from Oslo University Hospital in Norway, and colleagues examined the efficacy and safety of FMT in primary CDI in a randomized, open-label, noninferiority trial. The researchers found that clinical cure and no disease recurrence within 60 days without additional treatment was observed in 66.7 Frederik Emil Juul, M.D., Additional C.

article thumbnail

No Link Found for Preprocedural Fasting and Witnessed Pulmonary Aspiration

Physician's Weekly

from the UCLA School of Medicine in Los Angeles, and colleagues reviewed randomized clinical trials comparing outcomes from preprocedural fasting regimens and observational studies of witnessed aspiration events. Clinical aspiration was the main primary outcome. Stephanie Lam, D.O., percent, respectively]).

Clinic 52
article thumbnail

DASH Diet for Diabetes With Low Sodium Reduces BP in Those With Diabetes

Physician's Weekly

WEDNESDAY, June 18, 2025 (HealthDay News) — The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in people with diabetes, according to a study published online June 9 in JAMA Internal Medicine. For each diet, adverse events were infrequent.